Clonotype and repertoire changes drive the functional improvement of HIV-specific CD8 T cell populations under conditions of limited antigenic stimulation

Journal of Immunology

Volumn 188, Issue 3, 2012, Pages 1156-1167

  Janbazian, Loury ^a   Price, David A ^b,c   Canderan, Glenda ^d   Filali Mouhim, Abdelali ^a   Asher, Tedi E ^b   Ambrozak, David R ^b   Scheinberg, Phillip ^b   Boulassel, Mohamad Rachid ^e   Routy, Jean Pierre ^e   Koup, Richard A ^b   Douek, Daniel C ^b   Sekaly, Rafick Pierre ^a,d,f,g   Trautmann, Lydie ^d,g  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d Vaccine and Gene Therapy Institute of Florida   (United States)

^e ROYAL VICTORIA HOSPITAL   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD45RA ANTIGEN; INTERLEUKIN 7 RECEPTOR; PROGRAMMED DEATH 1 RECEPTOR; T LYMPHOCYTE RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; LONGITUDINAL STUDY; LYMPHOCYTE FUNCTION; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD45; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; GENE EXPRESSION REGULATION; HIV; HUMANS; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LONGITUDINAL STUDIES; PROGRAMMED CELL DEATH 1 RECEPTOR;

EID: 84856571506     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102610     Document Type: Article

References (65)

1. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68: 6103-6110.
2. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68: 4650-4655. (Pubitemid 24183063)
3. + T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189: 991-998.
4. + lymphocytes. Science 283: 857-860.
5. Betts, M. R., M. C. Nason, S. M. West, S. C. De Rosa, S. A. Migueles, J. Abraham, M. M. Lederman, J. M. Benito, P. A. Goepfert, M. Connors, et al. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789. (Pubitemid 43882629)
6. + T cells is reflected by their avidity, poly-functionality, and clonal turnover. J. Exp. Med. 204: 2473-2485.
7. +T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192: 63-75.
8. + T cells in chronic human immunodeficiency virus infection. Blood 96: 3094-3101.
9. + T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3: 1061-1068.
10. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927. (Pubitemid 36402840)
11. Wherry, E. J., and R. Ahmed. 2004. Memory CD8 T-cell differentiation during viral infection. J. Virol. 78: 5535-5545. (Pubitemid 38661640)
12. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354. (Pubitemid 44435155)
13. + T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
14. + T cells in peripheral blood after initiation of highly active antiretroviral therapy. J. Virol. 75: 6508-6516.
15. Ogg, G. S., X. Jin, S. Bonhoeffer, P. Moss, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, A. Hurley, et al. 1999. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J. Virol. 73: 797-800. (Pubitemid 28565430)
16. Altfeld, M., E. S. Rosenberg, R. Shankarappa, J. S. Mukherjee, F. M. Hecht, R. L. Eldridge, M. M. Addo, S. H. Poon, M. N. Phillips, G. K. Robbins, et al. 2001. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 193: 169-180. (Pubitemid 32524449)
17. + T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. J. Virol. 79: 12952-12960.
18. Barouch, D. H., J. Powers, D. M. Truitt, M. G. Kishko, J. C. Arthur, F. W. Peyerl, M. J. Kuroda, D. A. Gorgone, M. A. Lifton, C. I. Lord, et al. 2005. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nat. Immunol. 6: 247-252. (Pubitemid 41724761)
19. Friedrich, T. C., E. J. Dodds, L. J. Yant, L. Vojnov, R. Rudersdorf, C. Cullen, D. T. Evans, R. C. Desrosiers, B. R. Mothé, J. Sidney, et al. 2004. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat. Med. 10: 275-281. (Pubitemid 38667618)
20. Goulder, P. J., C. Brander, Y. Tang, C. Tremblay, R. A. Colbert, M. M. Addo, E. S. Rosenberg, T. Nguyen, R. Allen, A. Trocha, et al. 2001. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412: 334-338. (Pubitemid 32694384)
21. Leslie, A. J., K. J. Pfafferott, P. Chetty, R. Draenert, M. M. Addo, M. Feeney, Y. Tang, E. C. Holmes, T. Allen, J. G. Prado, et al. 2004. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10: 282-289. (Pubitemid 38667619)
22. + T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J. Virol. 82: 3391-3404.
23. + T cells. PLoS Med. 5: e100.
24. Vollbrecht, T., H. Brackmann, N. Henrich, J. Roeling, U. Seybold, J. R. Bogner, F. D. Goebel, and R. Draenert. 2010. Impact of changes in antigen level on CD38/PD-1 co-expression on HIV-specific CD8 T cells in chronic, untreated HIV-1 infection. J. Med. Virol. 82: 358-370.
25. Nikolich-Zugich, J., M. K. Slifka, and I. Messaoudi. 2004. The many important facets of T-cell repertoire diversity. Nat. Rev. Immunol. 4: 123-132. (Pubitemid 38209206)
26. Turner, S. J., P. C. Doherty, J. McCluskey, and J. Rossjohn. 2006. Structural determinants of T-cell receptor bias in immunity. Nat. Rev. Immunol. 6: 883-894. (Pubitemid 44851731)
27. Davenport, M. P., D. A. Price, and A. J. McMichael. 2007. The T cell repertoire in infection and vaccination: implications for control of persistent viruses. Curr. Opin. Immunol. 19: 294-300. (Pubitemid 46687007)
28. Venturi, V., D. A. Price, D. C. Douek, and M. P. Davenport. 2008. The molecular basis for public T-cell responses? Nat. Rev. Immunol. 8: 231-238. (Pubitemid 351323289)
29. Turner, S. J., N. L. La Gruta, K. Kedzierska, P. G. Thomas, and P. C. Doherty. 2009. Functional implications of T cell receptor diversity. Curr. Opin. Immunol. 21: 286-290.
30. low and display reduced variant cross-reactivity. J. Immunol. 186: 6871-6885.
31. Bernardin, F., B. L. Herring, L. Peddada, and E. L. Delwart. 2003. Primary infection of a male plasma donor with divergent HIV variants from the same source followed by rapid fluctuations in their relative frequency and viral recombination. AIDS Res. Hum. Retroviruses 19: 1009-1015. (Pubitemid 37476029)
32. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96. (Pubitemid 26332731)
33. Roederer, M., J. L. Nozzi, and M. C. Nason. 2011. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79: 167-174.
34. Douek, D. C., M. R. Betts, J. M. Brenchley, B. J. Hill, D. R. Ambrozak, K. L. Ngai, N. J. Karandikar, J. P. Casazza, and R. A. Koup. 2002. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J. Immunol. 168: 3099-3104. (Pubitemid 34211693)
35. + cells determined by a comprehensive DNA-based multiplex PCR for TCRB gene rearrangements. J. Immunol. Methods 321: 107-120.
36. Venturi, V., K. Kedzierska, M. M. Tanaka, S. J. Turner, P. C. Doherty, and M. P. Davenport. 2008. Method for assessing the similarity between subsets of the T cell receptor repertoire. J. Immunol. Methods 329: 67-80. (Pubitemid 350235463)
37. Sacre, K., G. Carcelain, N. Cassoux, A. M. Fillet, D. Costagliola, D. Vittecoq, D. Salmon, Z. Amoura, C. Katlama, and B. Autran. 2005. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease. J. Exp. Med. 201: 1999-2010. (Pubitemid 41002935)
38. Champagne, P., G. S. Ogg, A. S. King, C. Knabenhans, K. Ellefsen, M. Nobile, V. Appay, G. P. Rizzardi, S. Fleury, M. Lipp, et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410: 106-111. (Pubitemid 32225845)
39. Gattinoni, L., E. Lugli, Y. Ji, Z. Pos, C. M. Paulos, M. F. Quigley, J. R. Almeida, E. Gostick, Z. Yu, C. Carpenito, et al. 2011. A human memory T cell subset with stem cell-like properties. Nat. Med. 17: 1290-1297.
40. + T cell response. J. Immunol. 186: 359-371.
41. + T cell populations specific for persistent DNA viruses. J. Exp. Med. 202: 1349-1361.
42. + T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 110: 928-936.
43. Sauce, D., J. R. Almeida, M. Larsen, L. Haro, B. Autran, G. J. Freeman, and V. Appay. 2007. PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. AIDS 21: 2005-2013. (Pubitemid 47462149)
44. Rutebemberwa, A., S. C. Ray, J. Astemborski, J. Levine, L. Liu, K. A. Dowd, S. Clute, C. Wang, A. Korman, A. Sette, et al. 2008. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection. J. Immunol. 181: 8215-8225.
45. Blattman, J. N., E. J. Wherry, S. J. Ha, R. G. van der Most, and R. Ahmed. 2009. Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection. J. Virol. 83: 4386-4394.
46. Jenkins, M. R., K. Kedzierska, P. C. Doherty, and S. J. Turner. 2007. Heterogeneity of effector phenotype for acute phase and memory influenza A virusspecific CTL. J. Immunol. 179: 64-70. (Pubitemid 46986518)
47. Peixoto, A., C. Evaristo, I. Munitic, M. Monteiro, A. Charbit, B. Rocha, and H. Veiga-Fernandes. 2007. CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response. J. Exp. Med. 204: 1193-1205. (Pubitemid 46798161)
48. Daucher, M., D. A. Price, J. M. Brenchley, L. Lamoreaux, J. A. Metcalf, C. Rehm, E. Nies-Kraske, E. Urban, C. Yoder, D. Rock, et al. 2008. Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells. J. Virol. 82: 4102-4114. (Pubitemid 351521245)
49. + T cells after early HIV-1 infection. J. Virol. 81: 4199-4214.
50. Douek, D. C., R. D. McFarland, P. H. Keiser, E. A. Gage, J. M. Massey, B. F. Haynes, M. A. Polis, A. T. Haase, M. B. Feinberg, J. L. Sullivan, et al. 1998. Changes in thymic function with age and during the treatment of HIV infection. Nature 396: 690-695. (Pubitemid 29003949)
51. Vezys, V., D. Masopust, C. C. Kemball, D. L. Barber, L. A. O'Mara, C. P. Larsen, T. C. Pearson, R. Ahmed, and A. E. Lukacher. 2006. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J. Exp. Med. 203: 2263-2269. (Pubitemid 44498361)
52. Chun, T. W., D. C. Nickle, J. S. Justement, D. Large, A. Semerjian, M. E. Curlin, M. A. O'Shea, C.W. Hallahan, M. Daucher, D. J.Ward, et al. 2005. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J. Clin. Invest. 115: 3250-3255. (Pubitemid 41567589)
53. Palmer, S., F. Maldarelli, A. Wiegand, B. Bernstein, G. J. Hanna, S. C. Brun, D. J. Kempf, J. W. Mellors, J. M. Coffin, and M. S. King. 2008. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc. Natl. Acad. Sci. USA 105: 3879-3884. (Pubitemid 351723493)
54. + T-lymphocyte escape in simian immunodeficiency virus-infected macaques. J. Virol. 83: 8247-8253.
55. + T cell clonotypes in rhesus macaques. J. Immunol. 180: 269-280.
56. Venturi, V., M. F. Quigley, H. Y. Greenaway, P. C. Ng, Z. S. Ende, T. McIntosh, T. E. Asher, J. R. Almeida, S. Levy, D. A. Price, et al. 2011. A mechanism for TCR sharing between T cell subsets and individuals revealed by pyrosequencing. J. Immunol. 186: 4285-4294.
57. + T cell responses in vivo and in vitro. Proc. Natl. Acad. Sci. USA 96: 9781-9786.
58. Alexander-Miller, M. A., G. R. Leggatt, and J. A. Berzofsky. 1996. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl. Acad. Sci. USA 93: 4102-4107. (Pubitemid 26144250)
59. Derby, M., M. Alexander-Miller, R. Tse, and J. Berzofsky. 2001. High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J. Immunol. 166: 1690-1697. (Pubitemid 32114651)
60. Sedlik, C., G. Dadaglio, M. F. Saron, E. Deriaud, M. Rojas, S. I. Casal, and C. Leclerc. 2000. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity. J. Virol. 74: 5769-5775. (Pubitemid 30412943)
61. + T cell responses: correlation of cytokine profile and TCR avidity. J. Immunol. 172: 5553-5560.
62. Bihl, F., N. Frahm, L. Di Giammarino, J. Sidney, M. John, K. Yusim, T. Woodberry, K. Sango, H. S. Hewitt, L. Henry, et al. 2006. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J. Immunol. 176: 4094-4101. (Pubitemid 44264388)
63. + T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus. J. Immunol. 179: 3203-3213.
64. + T-cell polyfunctionality and HIV-suppressive activity. Blood 113: 6351-6360.
65. Perrin, H., G. Canderan, R. P. Sékaly, and L. Trautmann. 2010. New approaches to design HIV-1 T-cell vaccines. Curr. Opin. HIV AIDS 5: 368-376.